Requires insurance coverage of kidney function screening services
The introduction of HB 3422 could significantly alter healthcare policy in Missouri by mandating that insurers cover specific preventative services that were not previously guaranteed. This is expected to lead to an increase in the diagnosis and early treatment of chronic kidney disease, which is crucial as CKD often goes undiagnosed until its later stages. By ensuring coverage for such screenings, the state legislature is promoting a proactive approach to health that could alleviate the financial burden of untreated kidney diseases on both individuals and the healthcare system.
House Bill 3422 requires health carriers and health benefit plans operating in Missouri to provide insurance coverage for annual kidney function screening services, effective August 28, 2026. This mandate is designed specifically to identify patients who are at risk for chronic kidney disease (CKD). The types of screenings that must be covered include glomerular filtration rate testing, basic metabolic panel testing, and urine testing for albumin and creatinine levels. This bill aims to enhance early detection and intervention for kidney disease, potentially improving long-term health outcomes for affected individuals.
While the bill is framed as a necessary protective measure for public health, it might encounter opposition from insurance providers who may argue about the increased costs associated with mandating coverage for kidney screenings. There could be concerns about how this requirement interacts with existing policies and the potential for increased premiums as insurers adapt to the new obligations. Additionally, stakeholders in the industry might lobby for exemptions or modifications to the types of services covered under this mandate, highlighting the ongoing debate between ensuring comprehensive health coverage and managing healthcare costs.